Ocular Therapeutix, Inc.
OCUL
$11.87
-$0.43-3.50%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.87% | -32.37% | -32.60% | 16.64% | 32.49% |
| Total Depreciation and Amortization | 4.59% | 3.15% | -0.83% | 0.31% | 3.91% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -14.55% | 80.00% | 3,744.09% | -98.75% | -65.41% |
| Change in Net Operating Assets | -90.02% | 544.64% | 170.85% | -138.69% | 124.06% |
| Cash from Operations | -23.66% | -13.29% | -7.85% | -47.40% | 26.81% |
| Capital Expenditure | 35.59% | -856.93% | -126.97% | 88.01% | -190.98% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 42.32% | -856.93% | -126.97% | 88.01% | -190.98% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2,238.18% | -7.31% | 8.02% | 90.26% | -99.32% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,238.18% | -7.31% | 8.02% | 90.26% | -99.32% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 197.72% | -20.80% | -8.16% | -39.07% | -108.13% |